Philips (PHG) Financial Analysis & Valuation | Quarter Chart
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic re... more
Koninklijke Philips N.V. operates as a health technology company in North America and internationall... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $26.28B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | NL | CEO | Roy W. O. Jakobs |
| IPO Date | 1980-03-17 | CAGR | -0.66% |
| Employees | 66,401 | Website | www.philips.com |
| Div. Yield | 4.42% | Payout Ratio | 32% |
| Buy Back Yield | 0.38% | Total Yield | 4.8% |
PHG chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $29.45B | P/E | 15.37 | Forward P/E | 14.2 | PEG | 0.33 |
| P/S | 1.09 | P/B | 1.62 | P/CF | 8.14 | P/FCF | 10.03 |
| Sales | $20.12B | Sales 1Y | -1.08% | Sales 3Y | -3.84% | Sales 5Y | -7.22% |
| EPS | $1.75 | EPS 1Y | 582.35% | EPS 3Y | -152.02% | EPS 5Y | -1.55% |
| Sales QoQ | 11.65% | EPS QoQ | 150% | Sales QoQ Avg | 1.48% | EPS QoQ Avg | 45.2% |
| Gross Margin | 45.93% | Operating Margin | 10.17% | Profit Margin | 6.31% | ROCE | 9.32% |
| ROA | 4% | ROE | 10% | Altman Z Score | 2.04 | Piotroski Score | 7 |
| Current Ratio | 1.26 | Quick Ratio | 0.82 | Cash Ratio | 0.24 | Op. CF Ratio | 0.05 |
| Debt/Equity | 0.65 | Debt/Assets | 0.28 | Lt Debt/Equity | 0.55 | Lt Debt/Cap. | 0.36 |
| Intrst Cov. | 5.22 | Inventory Turnover | 2.97 | Asset Turnover | 0.66 | Receivables Turnover | 4.91 |
| Enterprise Value | $29.45B | P/E Ratio | 15.37 |
| Forward P/E | 14.2 | PEG Ratio | 0.33 |
| P/S Ratio | 1.09 | P/B Ratio | 1.62 |
| P/CF Ratio | 8.14 | P/FCF Ratio | 10.03 |
| EPS | $1.75 | EPS Growth 1Y | 582.35% |
| EPS Growth 3Y | -152.02% | EPS Growth 5Y | -1.55% |
| Revenue Growth 1Y | -1.08% | Gross Margin | 45.93% |
| Operating Margin | 10.17% | Profit Margin | 6.31% |
| ROE | 10% | ROA | 4% |
| ROCE | 9.32% | Current Ratio | 1.26 |
| Quick Ratio | 0.82 | Cash Ratio | 0.24 |
| Debt/Equity | 0.65 | Interest Coverage | 5.22 |
| Altman Z Score | 2.04 | Piotroski Score | 7 |
Philips (PHG) valuation & financials
Philips (PHG) has a market capitalization of $26.28B and trades at a price-to-earnings ratio of 15.4. It operates in the Healthcare sector (Medical - Devices).
Philips's revenue grew -1.1% over the last year.
Philips's next earnings report is scheduled for November 3, 2026 before market open (provider scheduled date); analysts estimate EPS of $0.37. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)